Researchers find lorlatinib to be safe and effective treatme

In a significant step for the treatment of neuroblastoma, an international group of researchers led by Children’s Hospital of Philadelphia (CHOP), Winship Cancer Institute of Emory University and the New Approaches to Neuroblastoma Therapy (NANT) Consortium has shown that the targeted therapy lorlatinib is safe and effective in treating high-risk neuroblastoma.

Related Keywords

Philadelphia , Pennsylvania , United States , Canada , France , United Kingdom , Yaelp Moss , Kelly Goldsmith , , Children Neuroblastoma Cancer Foundation , V Foundation For Cancer Research , Children Oncology Group , Blood Disorders Center , Alex Lemonade Stand Foundation , Catherine Elizabeth Blair Memorial Foundation , Wade Army , Ronan Thompson Foundation , Emory University School Of Medicine , Pfizer Inc , Baldrick Foundation , International Society Of Paediatric Oncology European Neuroblastoma , National Cancer Institute , Consortium Phase , Therapy Program , Winship Cancer Institute , Emory Universityand , New Approaches , Neuroblastoma Therapy , Nature Medicine , Oncology Group , International Society , Paediatric Oncology European Neuroblastoma , Cancer Centerat , Developmental Therapeutics Program , Emory University , Aflac Cancer , Emory University School , Solving Kids Cancer , Cancer Research , Lemonade Stand Foundation , Neuroblastoma Cancer Foundation ,